|
CRBP Corbus Pharmaceuticals Holdings Inc 1595097 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-22,969,000.00 |
| Balance Sheet |
|
Current Assets
|
$143,566,000.00 |
|
Assets
|
$144,480,000.00 |
|
Current Liabilities
|
$18,138,000.00 |
|
Liabilities
|
$18,138,000.00 |
|
Equity
|
$126,342,000.00 |
|
Shares Out
|
17738870.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-25,571,000.00 |
|
Investing Cash Flow
|
$22,455,000.00 |
| Market Analysis |
Market Cap
|
$160,536,773.50 |
|
Price
|
$8.84 |
|
BVPS
|
7.12 |
|
PB
|
1.27 |
|
EPS
|
-1.23 |
|
FCF
|
$-25,577,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:36 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:33 |
|
| Apr |
May |
Jun |
| 2026-03-09 |
-1.25 |
|
|
2026-05-12 |
-1.23 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-05 |
-1.44 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-1.90 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CRBP documents filed with the SEC.
CRBP Filings
Clear
